Latest Articles

We spoke with Professor Perry N. Halkitis, dean, distinguished professor and champion of LGBTQ+ rights, about the US FDA's recent reversal of its time-based deferrals and screening questions specific to gay and bisexual men for assessing blood donation eligibility.

This article will review the latest advances in next-generation sequencing technologies, data analysis tools and their various applications with key research examples.

A new molecule, based on the anti-diabetes drug metformin, can bind copper, found to be important in acute inflammation, sepsis and cancer dissemination, and thus holds great promise for new therapy.

In this opinion piece, Neil Ward discusses how the passing of the Genetic Technology "Precision Breeding" Bill could support global efforts to increase food production sustainably.

In this article, we review the latest research in cell therapy development, including advances made in the lab that show promise for translation to the clinic, to improvements in developing, testing and manufacturing.

In this article, we take a look at the risks that PFAS pose and how national governments and international institutions are introducing regulatory policies and guidelines aimed at stemming the tide of PFAS production and protecting the public from exposure.

This article sheds light on the issue of image integrity in academic publishing and gives advice on how to reduce the risk.

In this opinion piece, Sophie Peresson explores the need for greater visibility globally on biosecurity issues and strategic leadership from multiple stakeholders to drive the conversation around standards and best practices.

Jim Brooks shares top tips to overcome the biggest validation challenges and best practices for building and implementing a digital process data strategy to lead to smarter and faster validation.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.